GD100 gamma-delta T-cell programme questionsGD100 γδ-T细胞项目咨询
GD100 γδ-T细胞项目咨询GD100 gamma-delta T-cell programme questions
Gamma-delta T cells are an immune-cell population. A GD100 label does not specify whether cells are patient-derived or donor-derived, how they are expanded, or what disease is being studied. General immune enhancement is not a defined clinical endpoint.γδ-T细胞是一类免疫细胞。GD100名称未说明自体或供体来源、扩增方法及研究疾病，普遍增强免疫力不是明确临床终点。
Hospital named in the catalogue目录所列医院
Clinical details below are in English. Ask the care team for help understanding the source documents.
What to clarify
How assessment and planning work评估与规划如何进行
For this catalogue entry, the next useful document is a specification covering: cell source, target disease and a prespecified clinical endpoint. The receiving clinician should connect those details to the patient’s actual concern before suggesting tests, a schedule or travel.此目录条目下一步需要明确的资料是：细胞来源、目标疾病及预设临床终点。接诊医生应将这些信息与实际问题联系，再提出检查、频次或出行安排。
Before your consultation
The actual protocol, diagnosis if any, recent laboratory results and immune-modifying medicines.具体方案、诊断、近期检验及影响免疫的药物。
Send existing records for an initial discussion. Do not arrange new tests, change medication or book non-refundable travel solely from this page. The receiving team should state which additional information is actually needed.初步沟通可使用已有资料，不应仅凭本页安排新检查、改变用药或预订不可退款的行程。接诊团队应说明确实需要补充的资料。
Evidence and limitations
The material available for this named programme does not support a product-specific safety or effectiveness assessment. Possible interactions and procedure risks depend on what is actually supplied. A written product or protocol and the applicable clinical or research pathway are therefore required.现有资料不足以评估此项目具体产品的安全性或有效性，相互作用和操作风险取决于实际内容，因此需完整产品或方案以及适用的临床或研究路径。
Questions to ask
How would a γδ-T-cell proposal be assessed?如何评估γδ-T细胞方案？
Ask which defined disease or research endpoint is being targeted. A cell-type name does not establish a benefit for general immunity. The cell source, manufacturing checks, eligibility criteria and follow-up plan should be documented.应明确针对的疾病或研究指标。细胞名称不能证明能普遍增强免疫力，需有细胞来源、制备检测、入选条件和随访文件。
What should be included in my written treatment plan?书面诊疗方案应包括什么？
The treating team should identify the proposed intervention, alternatives, relevant uncertainty, clinical eligibility, anticipated visits, monitoring and arrangements if the plan changes after assessment. Ask who is responsible for follow-up after you return home.诊疗团队应明确拟议干预、替代方案、相关不确定性、适用条件、预计就诊次数、监测安排及评估后调整方案的处理方式，并说明回国后的随访负责人。
Price and quotation
Reference prices
CNY 89,000≈ USD 13,300Per injectionBoao Super Hospital
Request a quotationOriginal source
Patient pricebook · undated source · 康养项目 C2康养项目 C2
89000/针89000/针
Approximate conversion ·Central Bank of the UAE · exchange rates
Ask for an itemized provider quotation after the clinical team reviews your records. The scope may depend on the exact intervention, investigations, consumables, admission and monitoring. Confirm currency, validity period and what happens if the plan changes. Medical fees are paid directly to the provider; Uwell coordination is separate.临床团队审核资料后，可索取机构的分项报价。费用范围可能取决于具体干预、检查、耗材、住院和监测。应确认币种、有效期及方案调整后的计费方式。医疗费用直接向提供机构支付，优健云协调服务另行计费。
Reference catalogueSources and editorial scope
Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.
- National Cancer Institute: T-cell transfer therapy美国国家癌症研究所：T细胞转移治疗
- ClinicalTrials.gov: learn about studies美国临床试验登记：了解研究
The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.临床链接提供背景知识，不代表已核实具体医院项目、当前授权或个体治疗建议，相关信息须由提供机构确认。